Michael Bigham - Net Worth and Insider Trading
Michael Bigham Net Worth
The estimated net worth of Michael Bigham is at least $4 Million dollars as of 2024-11-28. Michael Bigham is the Exec. Chairman of the Board of Paratek Pharmaceuticals Inc and owns about 1,334,702 shares of Paratek Pharmaceuticals Inc (PRTK) stock worth over $3 Million. Michael Bigham is also the Director of Supernus Pharmaceuticals Inc and owns about 35,000 shares of Supernus Pharmaceuticals Inc (SUPN) stock worth over $1 Million. Details can be seen in Michael Bigham's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Bigham has not made any transactions after 2023-08-09 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Bigham
Michael Bigham Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Bigham owns 5 companies in total, including Adamas Pharmaceuticals Inc (ADMS) , Paratek Pharmaceuticals Inc (PRTK) , and Supernus Pharmaceuticals Inc (SUPN) among others .
Click here to see the complete history of Michael Bigham’s form 4 insider trades.
Insider Ownership Summary of Michael Bigham
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ADMS | Adamas Pharmaceuticals Inc | 2020-06-03 | director |
| PRTK | Paratek Pharmaceuticals Inc | 2023-08-09 | director & Exec. Chairman of the Board |
| SUPN | Supernus Pharmaceuticals Inc | 2013-03-22 | director |
 | | 2022-11-22 | director |
| | 2022-11-22 | director |
Michael Bigham Latest Holdings Summary
Michael Bigham currently owns a total of 2 stocks. Among these stocks, Michael Bigham owns 1,334,702 shares of Paratek Pharmaceuticals Inc (PRTK) as of August 9, 2023, with a value of $3 Million and a weighting of 69.69%. Michael Bigham also owns 35,000 shares of Supernus Pharmaceuticals Inc (SUPN) as of March 22, 2013, with a value of $1 Million and a weighting of 30.31%.
Latest Holdings of Michael Bigham
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PRTK | Paratek Pharmaceuticals Inc | 2023-08-09 | 1,334,702 | 2.23 | 2,976,385 |
| SUPN | Supernus Pharmaceuticals Inc | 2013-03-22 | 35,000 | 36.99 | 1,294,650 |
Holding Weightings of Michael Bigham
Michael Bigham Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Bigham has made a total of 11 transactions in Paratek Pharmaceuticals Inc (PRTK) over the past 5 years, including 0 buys and 11 sells. The most-recent trade in Paratek Pharmaceuticals Inc is the sale of 31,250 shares on August 9, 2023, which brought Michael Bigham around $68,750.
According to the SEC Form 4 filings, Michael Bigham has made a total of 0 transactions in Supernus Pharmaceuticals Inc (SUPN) over the past 5 years. The most-recent trade in Supernus Pharmaceuticals Inc is the acquisition of 35,000 shares on March 22, 2013, which cost Michael Bigham around $189,350.
Insider Trading History of Michael Bigham
- 1
Michael Bigham Trading Performance
GuruFocus tracks the stock performance after each of Michael Bigham's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Bigham is 5.59%. GuruFocus also compares Michael Bigham's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Bigham within 3 months outperforms 1 times out of 2 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Bigham's insider trading performs compared to the benchmark.
Performance of Michael Bigham
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.19 | | | | | |
| Relative Return to S&P 500(%) | -8.83 | | | | | |
Michael Bigham Ownership Network
Michael Bigham Owned Company Details
What does Adamas Pharmaceuticals Inc do?
Who are the key executives at Adamas Pharmaceuticals Inc?
Michael Bigham is the director of Adamas Pharmaceuticals Inc. Other key executives at Adamas Pharmaceuticals Inc include Chief Commercial Officer Vijay Shreedhar , Chief Financial Officer Christopher B Prentiss , and director & 10 percent owner William W. Ericson .
Adamas Pharmaceuticals Inc (ADMS) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Adamas Pharmaceuticals Inc (ADMS) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Adamas Pharmaceuticals Inc (ADMS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Adamas Pharmaceuticals Inc (ADMS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Adamas Pharmaceuticals Inc Insider Transactions
Michael Bigham Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Bigham. You might contact Michael Bigham via mailing address: 890 Winter Street, Waltham Ma 02451.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
